Colinz Laboratories

Colinz Laboratories CROIC

The Cash Return on Invested Capital (CROIC) of Colinz Laboratories (531210.BO) as of Oct 16, 2026 is 25.30 %. In the previous year, Cash Return on Invested Capital (CROIC) was -16.96 % — a change of -249.18% (higher).

CROIC

25.30 %

YoY

-249.18%

Last updated:

Cash Return on Invested Capital (CROIC) of Colinz Laboratories is 2026 25.30 % . Cash Return on Invested Capital (CROIC) of Colinz Laboratories was 2025 -16.96 % . It decreases by -249.18% higher compared to the previous year.

The Colinz Laboratories CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2019
1.54 INR
Jan 1, 2020
7.44 INR
Jan 1, 2021
24.15 INR
Jan 1, 2022
5.26 INR
Jan 1, 2023
4.79 INR
Jan 1, 2024
10.87 INR
Jan 1, 2025
-16.96 INR
Jan 1, 2026
25.30 INR
The Colinz Laboratories CROIC history
YEARCROICYoY
25.30 %-249.18%
-16.96 %-256.03%
10.87 %+126.97%
4.79 %-8.90%
5.26 %-78.23%
24.15 %+224.68%
7.44 %+381.89%
1.54 %-67.12%
4.69 %+756.20%
0.55 %-91.72%
6.62 %+678.25%
0.85 %-86.54%
6.32 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Colinz Laboratories Stock analysis

What does Colinz Laboratories do? Colinz Laboratories Ltd, listed on the Bombay Stock Exchange with ticker 531210.BO and ISIN INE923C01011, is a pharmaceutical company headquartered in Mumbai, India. The company operates within the Health Care sector, specifically in the Pharmaceuticals industry. It went public through an IPO on January 13, 2004. Colinz Laboratories is engaged in the manufacturing and marketing of pharmaceutical formulations across various dosage forms, including tablets, capsules, granules, liquid orals, injectables, ointments, and creams. The company's product portfolio targets several medical conditions, such as hypertension, cholesterol, diabetes, piles, pyrexia, and malaria, with specific offerings for gynecological treatments like morning sickness, infertility, intrauterine growth restriction (IUGR), and pregnancy maintenance. Additionally, it provides hematinic, antispasmodic, anti-inflammatory, anti-allergic, and medicated shampoo products. Colinz Laboratories markets its products directly within several Indian states, including Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, Madhya Pradesh, Chhattisgarh, and West Bengal, utilizing its own marketing team. The company's website is www.colinz.com. It is important to note that the company's operations and product details are based on the provided information without additional verification. Colinz Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Colinz Laboratories stock

Cash Return on Invested Capital (CROIC) of Colinz Laboratories is 25.30 % in 2026.

Cash Return on Invested Capital (CROIC) of Colinz Laboratories changed from -16.96 % to 25.30 %, representing a -249.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Colinz Laboratories since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Colinz Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Colinz Laboratories

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Colinz Laboratories